comunicato stampa

Modular Content Powers Omnichannel Engagement at Speed and Scale

16 febbraio 2023 | 13.03

LETTURA: 3 minuti

Digital marketing innovators cut time to market by more than half and drive more meaningful engagements across the biopharma industry with Veeva Vault PromoMats

BARCELONA, Spain, Feb. 16, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that biopharmas are leveraging Veeva Vault PromoMats for modular content to accelerate medical, legal, and regulatory (MLR) reviews and drive more impactful engagement across channels and regions. With eight of the top 10 biopharmas using Vault PromoMats for modular content, and over 20 emerging companies starting to set a foundation, the industry is making the push to digital to deliver personalized, compliant content faster, and at scale.

"Our customers are at the forefront of digital marketing, paving the way with new modular strategies for more scalable and effective content," said Pooja Ojala, vice president of commercial content at Veeva. "Veeva Vault PromoMats is the foundation helping teams balance efficiency with creativity to drive richer omnichannel experiences for healthcare professionals as well as their patients."

Partnering with customers across more than 35 countries to establish a modular content foundation, Vault PromoMats is helping teams quickly reuse content and bridge the gap across channels and geographies. Based on early indicators, a modular content approach is helping one customer reduce time to market by more than 50%. This stems from an increase in content reuse by 40% and an overall decrease in approval times by 30%. Another company is achieving 75% of approvals in a single review cycle, cutting costs by 19%.

Impact of Modular Content at Boehringer Ingelheim, Moderna, and Novo Nordisk:

"Modular content is a game-changer for content creation throughout the industry—we can repurpose assets across channels and personalize content faster than ever before," said Aleja Betancourt, global director of marketing operations at Novo Nordisk. "With Veeva Vault PromoMats, we have a library of pre-approved promotional content modules to streamline workflows and reduce time to market."

"As we advance towards a fully digital operating model, modular content is key to delivering compliant customer-specific experiences," said Kevin Rose, executive director of content excellence at Boehringer Ingelheim. "Partnering with Veeva helps us move from a standard approach to content planning and development to a highly-personalized model that transforms our customer relationships."

"Reusing pre-approved content modules and tailoring relevant content is crucial to our modular content strategy as we customize more memorable, omnichannel experiences," said Jason Benagh, director of global marketing operations at Moderna. "Veeva Vault PromoMats provides key capabilities like automated claims linking, global-to-local tracking, and content sharing to ensure digital assets are timely and compliant."

Additional InformationFor more on Veeva Vault PromoMats, visit: veeva.com/eu/PromoMats/ Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

Veeva Forward-looking StatementsThis release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2022, which you can find here (a summary of risks which may impact our business can be found on pages 39 and 40), and in our subsequent SEC filings, which you can access at sec.gov.